Longevity Therapeutics 2019 by Hanson Wade

Longevity Therapeutics is organized by Hanson Wade and will be held from Jan 29 - 31, 2019 at Argonaut Hotel, San Francisco, California, United States of America.

Description:
This Conference will bring together the leading biotech drug developers, academics, investors and pharma companies endeavoring to develop innovative therapies targeting age-related conditions.

Join them to collaboratively tackle specific challenges faced to develop these therapies – from discovery, to preclinical activities, translational research, clinical development, regulatory and commercial considerations – and uncover the details behind the latest developments in this space.

Speakers:
Aubrey de Grey - AgeX Therapeutics, Judith Campisi - Buck Institute for Research on Aging, Nathaniel David - Unity Biotechnology, Nir Barzilai - Albert Einstein College of Medicine, Samuel Agus - Biophytis, Steven Braithwaite - Alkahest Inc., Ronald Kohanski - National Institute on Aging, NIH, Mark Bamberger - Stealth BioTherapeutics, Marc Ramis-Castelltort - Senolytic Therapeutics Inc., Lorna Harries - University of Exeter Medical School, Lindsay Wu - UNSW Sydney, Life Biosciences, Kristen Fortney - BioAge Labs, Kelsey Moody - Antoxerene/Ichor Therapeutics

Time: 8:00 am - 5:00 pm

Pre-Conference Workshop will be held on Jan 29, 2019

Additional details will be posted as soon as they are available.